Navigation Links
Breast Augmentation – FDA Approves New Silicone Gel Implant
Date:6/22/2013

Los Angeles, CA (PRWEB) June 22, 2013

According to a June 14, 2013 NBC News report, titled “FDA Approves Mentor's New Silicone Gel Breast Implant,” the FDA has approved the Mentor MemoryShape Breast Implant, making it the fifth silicone implant to receive such approval in the United States. Though the approval comes with strict stipulations for monitoring patients, the FDA found the implant to be safe for use in breast augmentation and reconstruction. They did, however, require that the manufacturer commit to extensive additional testing and continued monitoring of the original test group (go to goo.gl/DX4vp).

“The approval of the MemoryShape breast implant means women now have another choice for their breast augmentation or reconstruction,” says Dr. Simon Ourian, Medical Director of Epione Beverly Hills.

According to the report, the FDA determined that women have a "reasonable" expectation of safety and that the side effects from the MemoryShape implant were similar to those experienced with other implants. These problems included hardening of the skin around the implants causing them to be encapsulated, an uneven appearance, and cracking. These complications are not unusual for any of the FDA approved silicone devices.

Further according to the NBC report, the FDA has required that Mentor carefully monitor the women in the study for an additional 10 years. Also, the company must monitor another 350 women who will receive a type of MemoryShape device for five full years. The FDA has further stipulated that Mentor study 2,500 additional women who get MemoryShape implants for ten years to watch for long-term problems. As another safeguard, Mentor must perform five control studies involving 10,750 women to watch for an association with diseases that include brain and cervical cancer.

“The testing before approval was extensive and the continued testing and monitoring required of Mentor by the FDA is strict and quite large in scope,” says Dr. Ourian, “reflecting the FDA's concern for possible links between implants and rare diseases.”

Dr. Ourian has been a pioneer in laser technology and non-invasive aesthetic procedures including Restylane, Juvéderm, Radiesse and Sculptra. These treatments are used for the correction or reversal of a variety of conditions such as acne, acne scars, skin discoloration, wrinkles, stretch marks, varicose veins, cellulite, and others. More information about silicone breast implants can be found on Epione’s website

Read the full story at http://www.prweb.com/releases/2013/6/prweb10859542.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. New Trends in Venezuela Raise Awareness of Breast-Feeding Benefits
2. Mercy Takes Leadership Role in Use of Medical Technology, Offering IORT for Breast Cancer Patients and New National Institute of Robotic Surgery at Mercy
3. Third Generation California Vintner Cheryl Indelicato Makes Strides in the Fight Against Breast Cancer
4. FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery
5. EORTC study opens for elderly patients with HER-2 positive metastatic breast cancer
6. Internationally Acclaimed Breast Augmentation Expert Announces the Launch of His New Website
7. Fat cells in breast may connect social stress to triple-negative breast cancer
8. Osteoporosis drug may help treat advanced hormone-sensitive breast cancer
9. Abnormalities in new molecular pathway may increase breast cancer risk
10. U.S. Supreme Court Invalidates Patents on Breast and Ovarian Cancer Genes
11. Protein protects against breast cancer recurrence in animal model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... , ... October 13, 2017 , ... PurhealthRX , ... Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize ... providing a CBD form that can be easily incorporated into liquid products, while reducing ...
(Date:10/13/2017)... Calif. (PRWEB) , ... October 13, 2017 , ... Many ... dementia. However, many long-term care insurance companies have a waiver for care if the ... 90-day elimination period, when the family pays for care, is often waived, so the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... , ... “America On The Brink”: the Christian history of the United States ... creation of published author, William Nowers. Captain Nowers and his wife, Millie, have ... thirty years in the Navy. Following his career as a naval aviator and ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
Breaking Medicine News(10 mins):
(Date:10/7/2017)...   Provista, a proven leader in the ... purchasing power, today announced a new resource area on ... is the online home for case studies, articles ... news releases, slideshows and events. ... resources at their fingertips, viewers can also watch short ...
(Date:10/2/2017)... , Oct. 2, 2017 Diplomat Pharmacy, ... 8th Day Software and Consulting, LLC , and named ... 8th Day Software, based in Tennessee , ... 8th Day expands EnvoyHealth,s service offerings for health care ... "In an interoperable ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, ... 2017 earnings conference call and webcast on Friday, November ... a.m. (EDT) and ending at approximately 8:30 a.m. (CDT) ... discussing the company,s 2017 financial performance and guidance for ... opportunities, initiatives to enhance operational performance, and long-range financial ...
Breaking Medicine Technology: